MedXpert

NORD Holding Small Cap GmbH & Co. KG ("NORD Holding Small Cap"), a fund advised by NORD Holding UBG ("NORD Holding"), acquires a majority stake in MedXpert GmbH ("MedXpert"), based in Eschbach, in the context of succession planning. NORD Holding's investment sets the basis for the further expansion of the fast-growing provider of thoracic implants.

MedXpert is a provider of implants and instruments for the human thorax, offering a broad product portfolio for functional, dynamic and stable fixation of bony structures. The implants are used for rib and sternum trauma, correction of thoracic deformities and extensive reconstructions.

MedXpert’s products are based on its patented and innovative clipping technology. This unique method allows for easy and stable application, making implantation easier for surgeons and contributing to improved patient healing and well-being. Known worldwide as "The Chest Wall Company", MedXpert is one of the few specialized providers in this segment.

MedXpert distributes its products in more than 40 countries worldwide. Through a clear focus on innovation and product development, as well as close collaboration with surgeons and research institutions, MedXpert continues to set new industry standards.

Building on the increasing relevance and demand for surgical rib stabilization, MedXpert will continue its successful growth path when partnering with NORD Holding. MedXpert's Managing Director, Johannes Mußler, states: "We are very pleased to have found NORD Holding as apartner for the further development of our company. Due to NORD Holding's extensive experience in the medical technology sector, their vast network of experts and hands-on mentality, we are highly motivated to jointly pursue numerous strategic growth opportunities".

"We are very proud to support MedXpert, a leading medical technology company, in its further expansion and to welcome it as the third company in our fund," says Jan Markus Drees, Partner at NORD Holding.

Johannes Fleck, Principal at NORD Holding, adds: "Through its strong customer focus and commitment to product development, MedXpert has established itself as one of the top three providers of thoracic implants in its core geographies. The company's excellent marketing and sales efforts form the foundation for our ambitions in furtherhigh-potential markets”.

On behalf of NORD Holding, the transaction was executed by Jan Markus Drees, Johannes Fleck, Margarita Decker and Sven Langelahn.

‍

Advisory firms involved in the transaction by NORD Holding:

Commercial: CODEX Partners GmbH

Financial: Crowe BPG (BPG Beratungs- und Prüfungsgesellschaft mbH)

Legal: act AC Tischendorf Rechtsanwälte Partnerschaft mbB

Tax: FRB-TAX

Quality Management / Regulatory: regular services rs GmbH

‍

About MedXpert

MedXpert GmbH is an innovative medical technology company based in Eschbach. Since its foundation in 2002, MedXpert has developed a unique product portfolio of implants for bony thorax indications. Within three product categories, implants and instruments are developed and distributed for the treatment of fractures and osteotomies of the ribs and sternum (STRACOS), for chest wall reconstruction, e.g. after tumour removal (STRATOS), and for the correction of thoracic deformities such as pectus excavatum or pectus carinatum (PES).

‍

More informationis available at: www.medxpert.de